LAG3 and lung cancer: A study showed that using IL-12 to boost the cytotoxicity of NK cells in a lung cancer model (BALB/c mice injected with 4T1 cells) increased the NK cell population expressing high levels of coinhibitory molecules, including LAG-3, which limited NK cell-mediated antimetastatic activity (98).